SAHPRA unpacks global accolade upon receiving WHO Maturity Level 3 (ML3)

The South African Health Products Regulatory Authority (SAHPRA) hosted a conversation on our recent accolade of attaining the World Health Organisation (WHO) Maturity Level 3 (ML3) for vaccine production.

We had invited some of our Executives, CEO Dr. Boitumelo Semete-Makokotlela, CRO Portia Nkambule, and COO Christelna Reynecke to unpack this global accolade by sharing insights and the impact of receiving this WHO rating.

Our conversation focused on:

• Understanding of the opportunities that come with an ML3 ranking for South Africa
• Improved understanding of the influence of ML3 on the African vaccine production industry
• The impact of ML3 on the South African economy and its citizens

Watch webinar recording below: